The following was created by Alison
Donaldson & Elizabeth Lank for Macmillan Cancer Support.
The document can be downloaded in its full and
original format from
here
(100kb PDF file)
Bob Grant – a Scottish influencer

Contents
Life-changing experiences
1990s: start of formal influencing activity
Making best use of practice visits
2001: leg problems return
108 miles on crutches to raise money for Macmillan
2004-2006: Chairman of the Scottish Cancer Group -
fresh opportunities to achieve improvements in Scotland
Support from all sides
Concluding reflection – motivated by personal experience
This is one of a series of portraits created by Alison Donaldson & Elizabeth
Lank for Macmillan Cancer Support, describing how Primary Care Cancer Leads in
England, and their equivalents in Scotland, Northern Ireland and Wales, have
influenced cancer care locally and nationally. These accounts are intended to
stimulate learning by describing how a charitable organisation can work with
doctors (as individuals and also as members of ‘communities of practice’) to
make a difference to people living with cancer. We wish to thank Bob Grant for
giving time to telling his life story and talking about his work and his
relationship with Macmillan. Please address queries to
jmaher@macmillan.org.uk or
alison@donaldson.demon.co.uk
Bob Grant – a Scottish
influencer
Bob Grant’s life is an extraordinary example of how a person who has survived
cancer and lived for years with the late effects of radiotherapy has succeeded
in becoming a national influence on the Scottish cancer scene. Since the early
1990s, he has held various advisory and lead positions and worked continuously
with Macmillan Cancer Support. Currently he is Chair of the Scottish Cancer
Group and also part of an NCRI group looking at cancer in teenage and young
people. He has drawn on the health problems he himself encountered from his
school days onwards into a strong personal motivation to improve patient care.
Life-changing experiences
In 1960, at the age of 14, Bob Grant started to find it difficult to walk to
school and his mother noticed he had developed a limp. Bob was told by the GP,
who saw him on more than one occasion, that it was just growing pains. But the
pains got worse and eventually, early in 1961, another partner in the practice
helped his mother get an emergency appointment at the hospital. At the time Bob
was told the result of his x-rays was “not good”, but it was only much later
that he found out that it was a bone tumour he had had – a non-Hodgkin’s
lymphoma in his thigh-bone (femur).
Bob spent several weeks in hospital in Aberdeen and Edinburgh and he recalls the
hospital experience as “quite difficult”. As he left to go to hospital in
Edinburgh, the Ward Sister in Aberdeen took his crutches away from him and he
was taken by ambulance to the station and put on a train without them. His
“welcome” in Edinburgh was not much better, so he had two experiences of
unsatisfactory care in one day. Looking back, Bob reflects that “a whole lot of
attitudes were wrong at the time”, and he hopes that young people receive better
care today – especially with the development of special adolescent units.
In Edinburgh, Bob was in a ward with other patients with advanced disease, and
yet he was never told he had cancer – his mother was anxious to keep the
knowledge from him. (Years later, Bob was to discover from reading his primary
care notes that there was “no great expectation of survival” at the time.)
After his treatment, Bob grew rapidly, but his two legs grew at different rates
and he ended up with one leg about three inches shorter than the other. He was
given a special shoe and managed well with it – skiing was the only activity he
had to give up.
Bob had always been interested in medicine but his personal experience had made
him “more enthusiastic than ever”. Despite the time lost from school, he got
into Aberdeen University medical school and graduated in 1970. About a year
later, with the help of a friend working in pathology, Bob managed to check his
own records, and it was then that he learned that his condition had been
non-Hodgkin’s lymphoma. It also occurred to him that he may have had a higher
dose of radiotherapy than would be normal today.
As we know, radiotherapy can affect both blood vessels and the lymphatic
vessels, and the effects can last for the rest of a person’s life.
During the next few years Bob embarked on a career in surgery with a special
interest in cancer medicine. He started with a house job in surgery in Aberdeen,
and then moved down to Glasgow to focus on a particular type of cancer research.
By now it was already becoming clear to him that general practice suited him
best – his best six weeks as a medical student had been those he spent in
general practice in Orkney. So when an opportunity came up to become a partner
in a practice in rural Dumfriesshire, he took it up. After five very interesting
years there, still keen to explore other career opportunities, Bob spotted a job
in the radiotherapy department at Addenbrooke’s Hospital in Cambridge, where he
spent two years doing clinical oncology and research. At the end of this spell
in Cambridge, he and his wife were keen to get back to Scotland. Eventually, in
1981, Bob settled into a two-doctor general practice in Fife, where he and his
family have remained until today.
It was in 1988 that “completely out of the blue” Bob developed new problems with
his leg. He woke up suddenly one night feeling terrible and shivering with a
fever and was admitted to the local infectious diseases unit. It turned out he
had septicaemia - the infection had settled into his bone at the tumour site and
was affecting all the soft tissues of his leg. He was off work for several
weeks.
Despite the “superb care” he enjoyed in the old Hospital for Infectious
Diseases, the problem was persistent. During the next few years, he had three
major operations, but every time he came off the antibiotics the infection
flared up again. By the early 1990s, Bob “was beginning to despair”. After yet
another flare-up, in about 1996, he was put on high-dose oral long-term
antibiotics and for a while his health picked up and was even “quite good”.
1990s: start of formal influencing activity
Meanwhile, in the early 1990s Bob embarked on his first formal “influencing
role”. He was appointed as a GP advisor to the Fife Health Board. In this
capacity, he developed an interest in acute services and enjoyed undertaking a
survey of GPs’ views of such services.
In about 1995, the Fife Health Board appointed another doctor, Sue Ibbotson, as
a Consultant in Public Health. Bob describes Sue’s appointment as “a breath of
fresh air”. This was the time of the Calman Hine report (on the future of cancer
services in the UK), which recommended the appointment of a Lead Cancer
Clinician in every area. Sue Ibbotson suggested that Fife create a Lead Team,
and she and Bob worked with St John Hattersley of Macmillan Cancer Relief’s
Office for Scotland and Northern Ireland (OSNI) to secure funding for it.
The Lead Clinician Team that was formed included John Wilson (lead clinician and
gastroenterologist), Murdina McDonald (a nurse) and a full-time administrator,
all of whom, like Bob, were Macmillan-funded. Bob himself was the first Lead GP
for Cancer in the UK (his full title was Macmillan Cancer GP for Fife). The team
enjoyed “fantastic backing” from the Fife Health Board, which picked up the
funding after Macmillan had pump-primed the posts. “Anything we said was done –
with the full backing of the Chief Executive.” For example, Sue Ibbotson,
working with the Chief Executive (Pat Frost) acting as Chair, succeeded in
setting up a Cancer Board for Fife. The Cancer Lead Team were able to present
their ideas on a quarterly basis to the Cancer Board and actions were
consistently carried through as a result, recalls Bob.
Bob’s Macmillan funding gave him four sessions a week of protected time and he
retained the Macmillan tag after the Macmillan funding ceased. His role as Lead
GP for Cancer continued until he retired, while the administrator, nurse and
lead clinician are all still there today.
Bob points to a whole range of factors that enabled the Cancer Lead Team concept
to work “extremely well”:
► It enjoyed high-level backing and “ownership” by the Health Board
executive
► It had its own suite of offices and full-time funded administration.
► John Wilson, as leader, was a “fabulous facilitator” and “kept the team
together”.
► Bob himself had already worked as a GP advisor to the Fife Health Board,
so becoming Lead Cancer GP “was not a jump, it was an evolution – I had
all the right contacts”.
► Each individual brought distinct skills to the team. For example,
Murdina was an important member from Bob’s point of view, since as a GP: “There
was no way I could get into the nursing situation.
We talked every week.”
► The weekly team meetings were crucial and could be used “to bring in
other significant people.”
► Last not least, the team had excellent links with Public Health in Fife:
“Most GPs have very little contact with Public Health. We had some strong
personalities in Public Health in Fife who could do things that I couldn’t. For
example, they made the questionnaire [for the survey of GPs’ views of acute
services] possible – it was a big task. Having a link with a strong public
health department opens doors to a range of skills, certainly in Scotland.”
Overall, then, the result was that the sum added up to much more than the parts.
Making best use of practice visits
While he was Lead GP for Cancer, Bob wanted to find out what GPs thought about
existing cancer services and so he started visiting local practices:
“I found they were keen to co-operate and I got loads of information
I wouldn’t have got via a questionnaire”.
Ultimately Bob visited every practice in the area - about 63 in total - a task
which took just under two years. During each visit he scribbled down some notes
and then, after the visit, went straight to the car and used a mobile dictaphone
to dictate a note. The typed-up note was then sent back to the practice in
question, inviting their comments. Next, Bob finalised the note and, after every
five visits, he collated them into a report, which he presented to the Fife
Cancer Board at its next meeting:
“The collated visit reports drove the agenda of the Cancer Board, because we were picking up so many concerns. We were bringing information from practices that was unknown to the Board. This really did make a difference, and I could go back to see the GPs again afterwards to show action was being taken. For example, we learned that there were deficiencies in the urological cancer service, so we worked with the consultants and lobbied for an extra consultant in this field.”
While Bob was pursuing his practice visits,
Sue Ibbotson was setting up “Specialty Liaison Groups” for all the major
cancers. For example, there were concerns about the breast service at the time
in Fife. Sue set up a breast group and Bob, significantly a GP and not a breast
surgeon himself, became the group’s Chair. He recalls how, at the first meeting,
he discovered that the breast surgeons from the two Fife hospitals hadn’t even
met before, so he was able to introduce them.
“The breast unit in one hospital was shut down and all the services were
focused on the other hospital. It was the only service in the whole of Scotland
that changed radically during the period of purchaser-provider contracting. It
had often been unsatisfactory (my patients were telling me of terrible things
happening) and now it was producing among the best results in Scotland.”
The period when Bob and his colleagues in the Fife Cancer Board had their best
influencing years was from about 1995 till 1999. After that, the political
set-up and the relationships all changed, with the Chief Executive of the Health
Board moving on, Sue Ibbotson moving away, and the Lead Clinician also changing.
Once the political backing was lost, the Cancer Board became much less effective
and people stopped turning up to meetings.
2001: leg problems return
One day in early 2001, while walking his dog, Bob fell and broke his bad leg. By
July that same year he was certain it was not going to heal as it was a
pathological fracture. After further investigations, in September 2001 Bob had a
“massive distal femoral prosthesis” inserted. After the operation he was quickly
walking again and feeling great, but once again after the antibiotics stopped he
became very ill with a fever. He was flown back to hospital and put on
intravenous antibiotics. It seemed that the only way was to stay on antibiotics
indefinitely.
In February 2002, Bob tried to go back to work part-time but found it very
difficult. So, after a whole year off work, he decided to take early retirement
in July that year. Over the summer the leg felt heavy and tired but Bob tried to
make the best of things and take a holiday in France. However, in October 2002
the fever returned – this time despite the hefty antibiotics. Bob was admitted
to the Infectious Diseases Unit in Dundee, where he received 10 days of
excellent care. However, Bob recalls:
“One day when I looked in the mirror I didn’t like what I saw: I
thought, if that was my patient, I would encourage them to go for amputation. So
that morning I said ‘I want amputation’.”
On 1 November 2002 he had a high transfemoral amputation. The operation went
well, the leg healed and he had no post-operative infections. Bob was home by
Christmas and walking on a prosthetic limb.
108 miles on crutches to raise money for Macmillan
During 2003, Bob was trying to get used to his prosthetic limb and was enjoying
getting active again. One day, he had the idea of raising money for Macmillan by
doing the entire coastal path walk around Fife – 108 miles in all. In August
2003, he set out with his family and dog, and they were joined by groups of
ramblers. Macmillan fundraisers organised press coverage and the walk succeeded
in raising £16,000 for Macmillan. Bob did the entire “walk” on crutches.
After the charity walk was over, Bob was fitted with a new prosthesis and became
quite agile on it. However, he began to notice a pain in his stump, which
disappeared as soon as he removed the prosthesis. After further investigations,
in April 2004 it became clear that the underlying cause was that the main artery
to the stump had got blocked off as a late reaction to the radiotherapy,
aggravated by wearing the false limb. So, in practice, from November 2003 Bob
ceased wearing a limb and instead got about “even faster than before” on some
good titanium crutches purchased from the USA via the internet.
Meanwhile, towards the end of 2003, around the around the time his stump was
beginning to give him problems, Bob’s permanent health insurance company had
suggested a review of his health. Three years had passed since he had last
consulted in earnest, and this was during a period of rapid change. The upshot
was that, after re-registering with the GMC, by July 2004 Bob was ready to join
a practice in Kirkcaldy, Fife as a salaried GP on a part-time basis.
Despite occasional problems with the stump, Bob’s general health was excellent.
During 2006, he returned to hospital to try once more to use an artificial limb.
With the limb he was given, he has found it possible to walk for a few hours a
week.
2004-2006: Chairman of the Scottish Cancer Group –
fresh opportunities to achieve improvements in Scotland
Following early retirement, Bob had given up his Lead GP role in Fife. However,
his interest in influencing cancer care did not cease. During the early 2000s
the concept of Managed Clinical Networks was coming in in Scotland and Bob
helped set up the first one, known as SCAN. It covered the southeast of Scotland
and he chaired the Primary Care Group within it.
Then, towards the end of 2004, the Scottish Cancer Group, which had been in
existence since about 2001, was going through some changes. It had previously
been chaired by Anna Gregor, the Scottish “Cancer Czar”, someone, in Bob’s
words, with a “clear view on where cancer services should be going”:
“Around that time there was agreement to re-jig the Scottish Cancer Group,
and the Chairman’s position was advertised internally through the three Scottish
Cancer Networks.”
In February 2005, Bob was interviewed and selected for the position of Chairman
of the Group. His first year as Chairman was “a really good year”. He learned to
understand the system and work with the Scottish Executive. Bob particularly
emphasises the collaboration with patient representatives:
“We’ve now got patient representatives in the Group and one of our key
aims is to make sure they can participate fully. I meet them one hour before
every meeting and we go through the agenda,
with me providing them with indepth background they would otherwise be unaware
of. I also stay at home the day before with my phone line open, so anyone can
phone me to discuss any background or politics behind an item.”
As well as chairing the meetings, in his first year Bob visited each of the five
Cancer Centres in Scotland. There was a lot to learn about them, as the last few
years have been a period of investment in hardware and staff:
“It’s very good to see improvements coming through. Several job
vacancies that were previously hard to fill have now been filled, and we are
tackling waiting times and improving patient care.”
At the end of 2005, Bob also joined the NCRI Clinical Studies Development group
looking at cancer in teenagers and young adults. The aim is to organise research
and to look at what’s been done, where there are gaps, and to coordinate
clinical trials. Given Bob’s personal experience as an adolescent, this
objective is clearly one that feels worth pursuing.
Support from all sides
Bob emphasises the generous support given to him during his period of chronic
illness from 1988 onwards by his partners and other staff members in the
practice in Markinch, Fife:
“Drs Stewart, Wallace – and later (in the final 2-3 years prior to my early
retirement in 2002) Dr Lawrence – all gave me immense support and inevitably had
to accept extra work during my absences. To have had unsupportive partners would
have made life during those times much more difficult.”
He also comments on how supportive his family have been, including his wife
Joan, his three daughters and his brother and sister: “They have all been
superstars”, says Bob.
Finally, Macmillan has also played its part:
“Macmillan has been absolutely crucial in Scotland in the whole
development of the Lead Cancer role and in keeping the GPs together. The support
I have received – from the Scottish end and also the London office – has been
incredible. Whichever way I turned there was support – financial and moral, as
well as the fundraising support for the coastal walk.”
Bob comments particularly that the OSNI meetings, which brought the Scottish
Macmillan GPs together once or twice a year, were very valuable for sharing
ideas.
While Chair of the Scottish Cancer Group, Bob feels he should stand back a bit
and be seen as unattached to any particular organisation. He is therefore
maintaining links with Macmillan while focusing mainly on the Scottish Cancer
Group.
Concluding reflection – motivated by personal experience
Asked how his personal experience of cancer and cancer treatment has influenced
his work, Bob Grant explains that it has been the “little things” he experienced
in hospital – the instances of less-than-excellent care – that particularly
influenced him. But good experiences were also a major factor – for example, one
doctor in Aberdeen was not only extremely good at caring but also kept in touch
with Bob after he left that hospital. As a result, Bob thinks he pays more
attention to his own patient care than he otherwise might have done – for
example, asking patients "Now before you go, is there anything else I can help
you with today?" at the end of each consultation.
As well as wanting to give best care to patients in his own practice, Bob’s
personal experiences have motivated him, as we have seen, to influence health
care more widely through the series of leadership roles he has taken up over the
years, including Lead GP on the Lead Cancer Team in Fife, member of the
Macmillan GP community in the UK, and subsequently member of the NCRI group
looking at cancer in young adults and Chair of the Scottish Cancer Group.